Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 Jun 13;34(22):2619–2626. doi: 10.1200/JCO.2016.67.1529

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 by American Society of Clinical Oncology

PMC Copyright notice

Fig 1. — Maximal change in tumor burden from baseline is shown. Changes in tumor burden are presented at the patient level (A) and at the lesion level (injected lesions in panel B and uninjected lesions in panel C). CR, complete response; irRC, immune-related response criteria; PD, progressive disease; PR, partial response; SD, stable disease. *Patient had a 99.8% reduction in tumor burden. †Patients had a confirmed complete response. ‡Patients had 100% reduction in tumor burden, but response was unconfirmed.